We are live on
!
Find out more
LWCA
Locust Wood Capital Advisers Portfolio holdings
AUM
$4.15B
1-Year Est. Return
31.06%
This Fund
S&P 500
This Quarter
Est. Return
+22.31%
1 Year Est. Return
+31.06%
3 Year Est. Return
+111.42%
5 Year Est. Return
+142.5%
10 Year Est. Return
+596.81%
AUM
$1.61B
AUM Growth
+$429M
(+36%)
Cap. Flow
+$33.3M
Cap. Flow
% of AUM
2.06%
Top 10 Holdings %
Top 10 Hldgs %
47.22%
Holding
65
New
10
Increased
19
Reduced
22
Closed
7
Avg Time Held Equity + Options
6
quarters
Top 10 Avg Time Held Equity + Options
3.2
quarters
Top 20 Avg Time Held Equity + Options
4.6
quarters
Avg Time Held Equity only
7.1
quarters
Top 10 Avg Time Held Equity only
2.5
quarters
Top 20 Avg Time Held Equity only
4.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$38.2M |
| 2 |
T-Mobile US
TMUS
|
+$25.7M |
| 3 |
Elevance Health
ELV
|
+$21.3M |
| 4 |
McDonald's
MCD
|
+$17.8M |
| 5 |
Blackstone Mortgage Trust
BXMT
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$36.1M |
| 2 |
Baxter International
BAX
|
+$28.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$27.9M |
| 4 |
Amazon
AMZN
|
+$24.4M |
| 5 |
Linde
LIN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.03% |
| 2 | Technology | 14.22% |
| 3 | Financials | 13.09% |
| 4 | Healthcare | 8.95% |
| 5 | Materials | 7.23% |
Similar funds
CWG
CC
MSI
JFG
TCM
GCM
CCMIC
CIC
Locust Wood Capital Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, Locust Wood Capital Advisers held 65 positions worth $1.61B, up 36% from $1.18B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Locust Wood Capital Advisers's Q2 2020 filing shows 10 new, 19 increased, 22 reduced and 7 closed positions. Its largest new stake was Boston Scientific: 1,059,880 shares worth $37.2M. The largest sale was Alibaba, an estimated $36.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
- Locust Wood Capital Advisers's largest Q2 2020 buy was Boston Scientific: 1,059,880 shares worth $37.2M.
- Locust Wood Capital Advisers added most to Elevance Health in Q2 2020, an estimated $21.3M increase.
- Locust Wood Capital Advisers's biggest Q2 2020 reduction was Baxter International, cutting an estimated $28.5M.
- Locust Wood Capital Advisers fully exited Alibaba in Q2 2020, selling an estimated $36.1M.
- Locust Wood Capital Advisers's ten largest holdings make up 47% of its $1.61B portfolio in Q2 2020.
- Locust Wood Capital Advisers opened 10 new positions and closed 7 in Q2 2020.
- Locust Wood Capital Advisers's portfolio value rose 36% quarter-over-quarter to $1.61B.
Based on Locust Wood Capital Advisers's 13F filing for Q2 2020, filed 21 Jul 2020.